Homocysteine competes for the peroxisome proliferator-activated receptor nuclear receptors.
Hayden
Melvin R
MR
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004032:Diet; D005492:Folic Acid / Q000008:administration & dosage; D006801:Humans; D020138:Hyperhomocysteinemia / Q000503:physiopathology* / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000009:adverse effects; D047492:Peroxisome Proliferator-Activated Receptors / Q000819:agonists*; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects
D007004:Hypoglycemic Agents; D047492:Peroxisome Proliferator-Activated Receptors; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D005492:Folic Acid